Unicycive Therapeutics (UNCY) EPS (Basic) (2020 - 2026)
Unicycive Therapeutics' (UNCY) quarterly EPS (Basic) came in at -$0.06 in Q2 2026, up 87.79% on a YoY basis from -$0.03 in Q2 2025, and up 88.07% quarter-over-quarter from -$0.54 in Q1 2026.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) EPS (Basic) (2020 - 2026) Analysis & Trends
Unicycive Therapeutics (UNCY) has reported EPS (Basic) for 7 consecutive years, with -$0.06 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 87.79% year-over-year to -$0.06; the trailing twelve-month figure through Jun 2026 stood at -$1.02 (up 60.24% YoY), and the FY2025 full-year result was -$1.8, up 68.15% from the prior year.
- EPS (Basic) grew to -$0.06 in Q2 2026 per UNCY's latest filing, from -$0.54 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.8 in Q2 2024 and bottomed at -$9.69 in Q1 2023.
- Historically, EPS (Basic) has averaged -$2.22 across 5 years, with a median of -$1.85 in 2022.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) jumped 127.53% in 2024, then sank 1328.63% in 2026.
- Over 5 years, EPS (Basic) stood at -$3.54 in 2022, then rose by 10.2% to -$3.18 in 2023, then retreated by 1.12% to -$3.21 in 2024, then soared by 86.48% to -$0.43 in 2025, then jumped by 85.27% to -$0.06 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.06, -$0.54, and -$0.43 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Unicycive Therapeutics | 143.47 Mn | 143.47 Mn | - | -0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | -0.54 |
| Dec 31, 2025 | -0.43 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.52 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -3.21 |
| Sep 30, 2024 | -0.46 |
| Jun 30, 2024 | 0.80 |
| Mar 31, 2024 | -6.06 |
| Dec 31, 2023 | -3.18 |
| Sep 30, 2023 | -1.35 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -9.69 |
| Dec 31, 2022 | -3.54 |
| Sep 30, 2022 | -3.69 |
| Jun 30, 2022 | -2.42 |
| Mar 31, 2022 | -2.36 |
| Dec 31, 2021 | -2.36 |
| Sep 30, 2021 | -3.67 |